Brief: Corline Biomedical Q2 Pre-Tax Loss Widens To SEK 2.5 Mln
Aug 28 (Reuters) - Corline Biomedical AB CLBIO.ST :
* Q2 NET SALES SEK 0.4 MILLION VERSUS SEK 0.3 MILLION YEAR
AGO
* Q2 PRE-TAX LOSS SEK 2.5 MILLION VERSUS LOSS SEK 1.9
MILLION YEAR
AGO
Source text for Eikon: ID:nGNE5wxPqp
Further company coverage: CLBIO.ST
(Reporting by Aleksandra Jasiurska)
((Aleksandra.Jasiurska@thomsonreuters.com;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln